Annals of Ophthalmology

, Volume 39, Issue 1, pp 51–52

Large subretinal hemorrhage after intravitreal bevacizumab (Avastin®) for age-related macular degeneration

Case Report

DOI: 10.1007/BF02697326

Cite this article as:
Chieh, J.J. & Fekrat, S. Ann Ophthalmol (2007) 39: 51. doi:10.1007/BF02697326

Abstract

We report the development of a large subretinal hemorrhage 4 weeks after intravitreal bevacizumab in an 84-year-old male with 20/70 visual acuity caused by occult choroidal neovascularization from neovascular agerelated macular degeneration in one eye that was treated with 1.25 mg of intravitreal bevacizumab.

Copyright information

© ASCO 2007

Authors and Affiliations

  1. 1.Duke University Eye CenterDurham
  2. 2.Department of OpthalmologyDuke University Medical CenterDurham